ByeAcne/Medication
Accutane vs Isotretinoin: Same Drug, Different Names
"Accutane" was the original brand name for isotretinoin. The brand was discontinued in 2009, but the medication is identical under generic and other brand names.
Reviewed by a licensed physician · Updated May 2026
The confusion between Accutane and isotretinoin is purely a naming issue. They're the same drug. Accutane was Hoffmann-La Roche's original brand name when the medication was first approved by the FDA in 1982. Roche discontinued the brand in 2009, largely in response to mounting legal liabilities (the company faced thousands of lawsuits alleging the drug caused inflammatory bowel disease, depression, and other serious effects). The medication itself — isotretinoin — has been continuously available since, as generic and under other brand names: Claravis (Teva), Amnesteem (Mylan), Myorisan (Sandoz), Absorica (Sun Pharma), and others.
For clinical purposes, the brand name doesn't matter. All these formulations contain the same active ingredient at the same doses and produce the same effects. Generic isotretinoin is bioequivalent to the original Accutane. The only meaningful pharmacological difference among them is Absorica's "Lidose" formulation, designed for better absorption that doesn't require taking with a fatty meal — useful for patients who struggle with the standard "fatty meal for absorption" requirement.
The drug itself is one of the most effective acne treatments available. A typical course is 5-7 months at a cumulative weight-based dose, with the goal of long-term remission. About 70% of patients who complete an adequate course see lasting clearance for years or permanently. For severe nodulocystic acne, scarring acne, or treatment-resistant cases, it's often the definitive option after other treatments have failed.
The trade-offs are substantial and unchanged regardless of brand name. iPLEDGE program enrollment for women of reproductive potential (monthly pregnancy tests, two forms of contraception, strict pregnancy prevention). Monthly bloodwork (lipid panels, liver function tests). Side effects: severe dry skin/lips/eyes, joint aches, elevated triglycerides, occasional mood effects, rare but serious risks. None of this changes based on whether the bottle says Accutane, Claravis, or generic isotretinoin.
Why isotretinoin can produce lasting remission
Isotretinoin works through multiple simultaneous mechanisms: drastic reduction in sebaceous gland size and activity (often persistent after the drug clears), normalization of follicular shedding, anti-inflammatory effects, and reduction of C. acnes. The sebaceous gland reduction in particular is partly persistent — even after treatment ends, glands often remain smaller for years. This is the biological basis for long-term remission rates around 70% with adequate cumulative dose.
Adequate cumulative dose matters. The original Accutane studies established that lower total doses correlate with higher relapse rates. The typical target is 120-150mg/kg total, achieved over 5-7 months at daily doses of 0.5-1mg/kg. Stopping early or at lower cumulative doses produces shorter remissions and higher relapse rates.
Treatment options a doctor may consider
- Isotretinoin 0.5-1mg/kg daily, 5-7 months
Standard course. Cumulative target 120-150mg/kg. Monthly bloodwork and pregnancy tests (women).
- Absorica (Lidose formulation)
Better absorption without fatty meal requirement. Same efficacy, slightly more convenient.
- iPLEDGE enrollment (women)
Required for any woman of reproductive potential. Monthly pregnancy tests, two contraception forms.
- Specialist referral
Most physicians refer to dermatology for prescribing. Limited telehealth pathways exist.
Your specific regimen depends on your medical history, current medications, and intake photos. Only your physician can determine what's appropriate.
Who this applies to
Patients with severe acne, nodulocystic acne, scarring acne, or treatment-resistant acne. Also anyone confused about whether Accutane and isotretinoin are different drugs — they're not.